IDENIX PHARMACEUTICALS INC (IDIX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

320 BENT STREET CAMBRIDGE, MA 02141

Engages in the discovery and development of drugs for the treatment of human viral and other infectious diseases. The company's focus has been on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus (HIV).

View SEC Filings from IDIX instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding IDIX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IDIX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NOVARTIS PHARMA AG

NOVARTIS AG

  • 10% Owner
No longer subject to file 2014-08-05 0

WYZGA MICHAEL S

  • Director
No longer subject to file 2014-08-05 0

MAYERS DOUGLAS L EVP AND CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2014-08-05 0

FANNING PAUL SVP, HUMAN RESOURCES

  • Officer
No longer subject to file 2014-08-05 0

STAHL MARIA D SVP & GENERAL COUNSEL

  • Officer
No longer subject to file 2014-08-05 0

RENAUD RONALD C JR PRESIDENT & CEO

  • Officer
  • Director
No longer subject to file 2014-08-05 0

BECKMAN DANIELLA SVP, CFO AND TREASURER

  • Officer
No longer subject to file 2014-08-05 0

POLLARD-KNIGHT DENISE

  • Director
No longer subject to file 2014-08-05 0

HOWSON TAMAR D

  • Director
No longer subject to file 2014-08-05 0

HODGSON THOMAS R

  • Director
No longer subject to file 2014-08-05 0

HOCKMEYER WAYNE T

  • Director
No longer subject to file 2014-08-05 0

ROWLAND CHARLES A JR

  • Director
No longer subject to file 2014-08-05 0

BAUPOST GROUP LLC/MA

SAK CORP

KLARMAN SETH A

  • 10% Owner
No longer subject to file 2014-08-05 0

DUMAS JACQUES EVP, CHIEF SCIENTIFIC OFFICER

  • Officer
No longer subject to file 2014-08-05 0

BAUPOST GROUP LLC/MA

BAUPOST VALUE PARTNERS LP IV

SAK CORP

KLARMAN SETH A

  • 10% Owner
36,910,868 2013-11-01 0

STANDRING DAVID EVP & CHIEF SCIENTIFIC OFFICER

  • Officer
0 2013-02-20 0

ROSENBERG ANTHONY

  • Director
0 2012-12-31 0

BROOKSIDE CAPITAL MANAGEMENT LLC

BROOKSIDE CAPITAL TRADING FUND, L.P.

BROOKSIDE CAPITAL INVESTORS II, L.P.

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2012-08-07 0

GOFF BRIAN

  • Director
0 2012-03-27 0

CRAMB CHARLES W JR

  • Director
0 2011-06-02 0

SOMMADOSSI JEAN-PIERRE PRESIDENT, CEO, CHAIRMAN

  • Officer
  • Director
0 2010-02-10 0

WEIDENBRUCH JOHN EX. VP, GEN. COUNSEL AND SECR.

  • Officer
0 2010-02-10 0

THOMAS-GRAHAM PAMELA

  • Director
0 2009-06-02 0

PROJAN STEVEN

  • Director
0 2009-02-03 0

PAYSON NORMAN C MD

  • Director
0 2008-06-03 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments